jbainseky, the exact language was posted here past week or the week before if my memory is good. I don't have search facility on here. It was ALSO in a CC and a reply to a question from an analyst.
Shan (transcript CC):
Secondly, when we powered the study, in the Ph2 study we saw about a 4mos. difference in median OS, and the SUNRISE study was designed to really show a statistical difference even at 2mos; we built in some powering assumptions we think will give us some opportunity there should be arms behave in a way that was little bit unexpected. So, we’ve tried to hedge against that going into the stage design and we think we’re in good shape and now it’s just a matter of getting the readouts
Unfortunately it wasn't just a "little bit unexpected" it was "dramatically unexpected" and that is where we have a 'shot' given all I explained in my past posts.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.